Skip to content

Research for my child. Clinical studies in Switzerland

This platform is aimed at families with a child or adolescent with cancer. Here you will find reliable, easy-to-understand information on open clinical trials in Switzerland - regardless of which of the nine paediatric oncology treatment centres your child is being treated at.

Our aim is to provide you with guidance and facilitate access to possible treatment options in the context of clinical research. Each study is described in clear, easy-to-understand language. Structured programmes (for example, Early Access Programmes) that provide access to a medicine not yet commercially available are also included in this database. This way, you can quickly find out whether a therapy might be suitable for your child.

Open clinical trials

Select filter:
studies found

AcSé-ESMART

Therapy study based on targeting molecular changes in refractory or recurrent tumours

0 - 18 years
+

ALCL-VBL

ALCL-VBL: An international clinical study for children and adolescents with standard-risk ALK-positive anaplastic large cell lymphoma

0 - 17 years
+

ALL SCTped 2012 FORUM

Blood stem cell transplantation in children and adolescents with acute leukaemia

0 - 21 years
+

CHIP-AML22 Master Protocol

A clinical trial for the treatment of children and adolescents with newly diagnosed acute myeloid leukemia

0 - 18 years
+

FaR-RMS

FaR-RMS: A study for children and adults with newly diagnosed or relapsed rhabdomyosarcoma (RMS)

0+ years
+

HR-NBL2/SIOPEN

Study on high-risk neuroblastoma (HR-NBL) conducted by the European Neuroblastoma Group of the International Society of Paediatric Oncology (SIOP)

0 - 17 years
+

INFORM2 NivEnt

An international Phase I/II combination study with nivolumab and entinostat in children and adolescents with recurrent or refractory (treatment-resistant) tumours

2 - 21 years
+

InO (B1931036)

A study comparing inotuzumab ozogamicin (abbreviated to InO) with ALLR3 (a multi-agent chemotherapy) for the treatment of childhood leukaemia

1 - 18 years
+

IntReALL HR 2010

International study for the treatment of children and adolescents with relapsed acute lymphoblastic leukaemia (ALL) at high risk

0 - 17 years
+

ITCC-101/APAL

A study of fludarabine/cytarabine/gemtuzumab ozogamicin with or without venetoclax in children with recurrent acute myeloid leukaemia

0 - 21 years
+

LBL 2018

LBL 2018, international cooperative treatment protocol for children and adolescents with lymphoblastic lymphoma (LBL)

0 - 17 years
+

LOGGIC/Firefly-2

A randomised, international, multicentre phase III trial of DAY101 monotherapy versus standard chemotherapy in patients with paediatric low-grade glioma with an activating RAF alteration requiring first-line systemic therapy

0+ years
+

ML-DS 2018

Phase III clinical trial with CPX-351 in children with Down syndrome 2018

0 - 6 years
+

rEECur

International randomised clinical study for patients with relapsed or treatment-refractory Ewing sarcoma

2+ years
+

SCRIPT-AML

Clinical study on conditioning regimens before paediatric transplantation in acute myeloid leukaemia

0 - 21 years
+

SIOP Ependymoma II

An international clinical study programme aimed at optimising the diagnosis and treatment of children, adolescents, and young adults with ependymoma.

0 - 21 years
+

SIOP Randomet 2017

A randomised phase III clinical trial for children and adolescents with stage IV nephroblastoma conducted by the Renal Tumour Study Group of the International Society of Paediatric Oncology (SIOP–RTSG)

0 - 17 years
+

SIOP-HRMB

International study for patients with high-risk medulloblastoma

5+ years
+

SIOPE ATRT01

An international clinical study for children and adolescents with atypical teratoid/rhabdoid tumours

0 - 17 years
+

Sites

In Switzerland, there are nine specialised centres for the treatment of children and adolescents with cancer. Clinical trials are also carried out there - they test new therapies to improve treatment. This platform helps you to find suitable trials - regardless of the treatment centre. It is best to discuss whether a trial is suitable with your treatment team.
Basel Aarau Zürich St. Gallen Luzern Bern Lausanne Genève Bellinzona

Together for young cancer patients

This platform is operated by the Swiss Paediatric Oncology Group (SPOG) and financed by Zoé4Life. It shows clinical trials that are open to children and adolescents with cancer in Switzerland. The study information is submitted by the respective study organisers and reviewed by an internal SPOG expert committee before publication. The platform is independent, transparent and serves exclusively to provide information and guidance for affected families.

SPOG

SPOG is a non-profit association that has been dedicated to clinical paediatric cancer research for almost 50 years. Its members are the nine centres that treat children and adolescents with cancer. The aim is to improve the treatment and quality of life of young patients through high-quality studies. SPOG is active throughout Switzerland and has an international network. Its coordination centre is located in Bern.

SPOG

Zoé4Life

Zoé4Life is a non-profit organisation that supports children with cancer and their families. It provides financial support for affected families, promotes projects for children in hospital and organises events to raise awareness of childhood cancer. The majority of the funds are used to support paediatric cancer research with the aim of improving the chances of recovery and providing access to innovative therapies. In addition, Zoé4Life also finances projects during and after treatments to improve the quality of life of young people affected by cancer.

Zoé4Life